Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
CY Huang, M Cheng, NR Lee, HY Huang… - International journal of …, 2020 - mdpi.com
The use of weekly chemotherapy for the treatment of patients with advanced-stage serous-
type epithelial Tubo-ovarian cancer (ETOC), and primary peritoneal serous carcinoma …
type epithelial Tubo-ovarian cancer (ETOC), and primary peritoneal serous carcinoma …
[HTML][HTML] Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of …
S Chraibi, R Rosiere, E De Prez, P Gérard… - Biomedicine & …, 2021 - Elsevier
Despite the advances in targeted therapies and immunotherapy for non-small cell lung
cancer (NSCLC) patients, the intravenous administration of carboplatin (CARB) and …
cancer (NSCLC) patients, the intravenous administration of carboplatin (CARB) and …
[HTML][HTML] Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4–6 inhibitors?
I Gültürk, R Colak, C Kapar, M Guliyev, C Yıldırım… - The Breast, 2024 - Elsevier
Abstract Introduction Cyclin Dependent Kinase (CDK) 4–6 inhibitors are the recommended
first-line treatment option for hormone-positive metastatic breast cancer (MBC). They show …
first-line treatment option for hormone-positive metastatic breast cancer (MBC). They show …
Efficacy and safety of TC dose-dense chemotherapy as first-line treatment of epithelial ovarian cancer: a single-institution retrospective cohort study
Background The optimal first-line therapy of advanced ovarian cancer still remains
questionable: standard paclitaxel–carboplatin (TC), dose-dense TC, intraperitoneal …
questionable: standard paclitaxel–carboplatin (TC), dose-dense TC, intraperitoneal …
The relevance of macrocytosis induction during neoadjuvant dose-dense chemotherapy in breast cancer patients
The aim of this study was to explore the red blood cell changes that occur during
neoadjuvant dose-dense chemotherapy (NAC) of breast cancer. Also, we investigated the …
neoadjuvant dose-dense chemotherapy (NAC) of breast cancer. Also, we investigated the …
Comment on “clinical importance of mean corpuscular volume as a prognostic marker after esophagectomy for esophageal cancer: A retrospective study”
QJ Mao, PJ Yan, Y Liang - Annals of Surgery, 2021 - journals.lww.com
1. Hasselgren K, Rosok BI, Larsen PN, et al. ALPPS improves survival compared with TSH
in patients affected of CRLM: survival analysis from the randomized controlled trial LIGRO …
in patients affected of CRLM: survival analysis from the randomized controlled trial LIGRO …